Publications by authors named "Laura Piccoli"

Claim this Profile
A
A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential.
Susan A Greenfield, Gregory M Cole, Clive W Coen, Sally Frautschy, Ram P Singh, Laura Piccoli

Alzheimers Dement (N Y)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From High-Throughput Screening to Target Validation: Benzo[]isothiazoles as Potent and Selective Agonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 5 Possessing In Vivo Gastrointestinal Prokinetic Activity in Rodents.
Alessio Barilli, Laura Aldegheri, Federica Bianchi, Laurent Brault, Daniela Brodbeck, Laura Piccoli

J Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of bla TEM-220 gene in Penicillinase-producing Neisseria gonorrhoeae strains carrying Toronto/Rio plasmid in Argentina, 2002 - 2011.
Ricardo Gianecini, Claudia Oviedo, Cristina Guantay, Laura Piccoli, Graciela Stafforini

BMC Infect Dis· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
Romano Di Fabio, Giuseppe Alvaro, Simone Braggio, Renzo Carletti, Philip A Gerrard, Laura Piccoli

Bioorg Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats.
Laura Piccoli, Maria Vittoria Micioni Di Bonaventura, Carlo Cifani, Vivian J A Costantini, Mario Massagrande

Neuropsychopharmacology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders.
Romano Di Fabio, Annalisa Pellacani, Stefania Faedo, Adelheid Roth, Laura Piccoli

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists.
Alessandro Gozzi, Giuliano Turrini, Laura Piccoli, Mario Massagrande, David Amantini

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.
Massimo Gianotti, Maurizio Botta, Stephen Brough, Renzo Carletti, Emiliano Castiglioni, Laura Piccoli

J Med Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.
Massimo Gianotti, Corrado Corti, Sonia Delle Fratte, Romano Di Fabio, Colin P Leslie, Laura Piccoli

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic potential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion technique.
Maria Pia Montanari, Laura Piccoli, Marina Mingoia, Federico Marchetti, Pietro Emanuele Varaldo

Diagn Microbiol Infect Dis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-kill curves as a tool for targeting ceftazidime serum concentration during continuous infusion.
Laura Piccoli, Monica Larosa, Federico Marchetti

J Antimicrob Chemother· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories.
Giovanni Pietro Gesu, Federico Marchetti, Laura Piccoli, Annalisa Cavallero

Antimicrob Agents Chemother· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis